LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 145 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $177,000 | -63.8% | 14,400 | -51.5% | 0.06% | -57.9% |
| Q2 2017 | $489,000 | -2.2% | 29,710 | -14.8% | 0.14% | +17.6% |
| Q1 2017 | $500,000 | +3.7% | 34,870 | 0.0% | 0.12% | +8.2% |
| Q4 2016 | $482,000 | -24.9% | 34,870 | -1.9% | 0.11% | -27.6% |
| Q3 2016 | $642,000 | – | 35,540 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $62,009,000 | 100.00% |
| Artal Group S.A. | 57,517,977 | $825,383,000 | 17.04% |
| NEA Management Company, LLC | 2,382,286 | $34,186,000 | 1.77% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $512,000 | 1.49% |
| BRIDGER MANAGEMENT, LLC | 1,029,926 | $14,779,000 | 0.95% |
| FALCON POINT CAPITAL, LLC | 287,809 | $4,130,000 | 0.71% |
| HANCOCK WHITNEY CORP | 664,025 | $9,529,000 | 0.40% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 494,380 | $7,094,000 | 0.39% |
| ELLINGTON MANAGEMENT GROUP LLC | 11,700 | $168,000 | 0.23% |
| Convergence Investment Partners, LLC | 114,157 | $1,638,000 | 0.22% |